Mototsugu Watanabe

Acquisition of cancer stem cell‐like properties in non‐small cell lung cancer with acquired resistance to afatinib

Shinsuke Hashida, Hiromasa Yamamoto, Kazuhiko Shien et al. · Cancer Science · 2015 · 83 citations · Full text

Medicine, Oncology, Pharmacology +16

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring <i> <scp>HER</scp> 2 </i> oncogene alterations

Ken Suzawa, Shinichi Toyooka, Masakiyo Sakaguchi et al. · Cancer Science · 2015 · 76 citations · Full text

Medicine, Oncology, Pharmacology +17

Estimation of age-related DNA degradation from formalin-fixed and paraffin-embedded tissue according to the extraction methods

Mototsugu Watanabe, Shinsuke Hashida, Hiromasa Yamamoto et al. · Experimental and Therapeutic Medicine · 2017 · 74 citations · Full text

Medicine, Molecular Biology, Pathology +15

Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features

Hiroki Sato, Kazuhiko Shien, Shuta Tomida et al. · Scientific Reports · 2017 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +17

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

Tatsuaki Takeda, Hiromasa Yamamoto, Hirotaka Kanzaki et al. · PLoS ONE · 2017 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17